Lipoprotein-binding proteins in the human platelet plasma membrane

Area of Science:

• Biochemistry
• Cell Biology
• Cardiovascular Research

Background:

• Plasma lipoproteins play vital roles in lipid transport and cardiovascular health.
• Understanding lipoprotein interactions with cell surfaces is key to elucidating their physiological functions.
• Human blood platelets possess membrane receptors that may interact with circulating lipoproteins.

Purpose of the Study:

• To investigate the specific binding of homologous plasma lipoproteins to human blood platelet membrane receptors.
• To characterize the molecular weight of platelet proteins involved in lipoprotein binding.
• To determine factors influencing the binding affinity and reversibility of these interactions.

Main Methods:

• Ligand blotting techniques were employed to study lipoprotein binding.
• Saturable binding assays were performed using High-Density Lipoprotein 3 (HDL3), High-Density Lipoprotein 2 (HDL2), and Low-Density Lipoprotein (LDL).
• The influence of calcium ions (Ca2+) and modifications of apoprotein residues was assessed, along with the effect of heparin and suramin on binding reversibility.

Main Results:

• HDL3, HDL2, and LDL demonstrated saturable binding to distinct platelet membrane protein bands at 156, 130, and 115 kDa, respectively.
• Lipoprotein binding was largely unaffected by the presence or absence of Ca2+.
• Covalent modification of lysine and arginine residues on apoproteins did not significantly alter binding, but heparin and suramin almost completely reversed the binding.

Conclusions:

• Human blood platelets possess specific receptors for HDL3, HDL2, and LDL, binding to proteins of 156, 130, and 115 kDa.
• The binding mechanism is independent of Ca2+ and protein primary amine/guanidino groups.
• Heparin and suramin are effective in reversing lipoprotein binding, suggesting potential therapeutic targets for modulating lipoprotein-platelet interactions.